- Home
- RGS vs GANX Comparison
RGS vs GANX Comparison
Compare RGS & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGS
- GANX
- Stock Information
- Founded
- RGS 1922
- GANX 2017
- Country
- RGS United States
- GANX United States
- Employees
- RGS N/A
- GANX N/A
- Industry
- RGS Other Consumer Services
- GANX Biotechnology: Pharmaceutical Preparations
- Sector
- RGS Consumer Discretionary
- GANX Health Care
- Exchange
- RGS Nasdaq
- GANX Nasdaq
- Market Cap
- RGS 44.6M
- GANX 45.8M
- IPO Year
- RGS 1991
- GANX 2021
- Fundamental
- Price
- RGS $19.05
- GANX $2.03
- Analyst Decision
- RGS
- GANX Strong Buy
- Analyst Count
- RGS 0
- GANX 5
- Target Price
- RGS N/A
- GANX $8.20
- AVG Volume (30 Days)
- RGS 8.4K
- GANX 314.5K
- Earning Date
- RGS 05-13-2025
- GANX 05-13-2025
- Dividend Yield
- RGS N/A
- GANX N/A
- EPS Growth
- RGS N/A
- GANX N/A
- EPS
- RGS 40.46
- GANX N/A
- Revenue
- RGS $191,336,000.00
- GANX N/A
- Revenue This Year
- RGS N/A
- GANX N/A
- Revenue Next Year
- RGS N/A
- GANX N/A
- P/E Ratio
- RGS $0.51
- GANX N/A
- Revenue Growth
- RGS N/A
- GANX N/A
- 52 Week Low
- RGS $3.87
- GANX $0.89
- 52 Week High
- RGS $35.50
- GANX $3.19
- Technical
- Relative Strength Index (RSI)
- RGS 55.03
- GANX 54.26
- Support Level
- RGS $17.50
- GANX $1.85
- Resistance Level
- RGS $19.50
- GANX $2.27
- Average True Range (ATR)
- RGS 1.07
- GANX 0.16
- MACD
- RGS 0.17
- GANX 0.02
- Stochastic Oscillator
- RGS 81.86
- GANX 59.17
About RGS Regis Corporation
Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.